

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | urate metabolic process (GO:0046415) | 8.26986397 |
| 2 | drug transmembrane transport (GO:0006855) | 8.08886427 |
| 3 | aminoglycoside antibiotic metabolic process (GO:0030647) | 7.75165984 |
| 4 | glyoxylate metabolic process (GO:0046487) | 6.99191062 |
| 5 | lysine catabolic process (GO:0006554) | 6.92850819 |
| 6 | lysine metabolic process (GO:0006553) | 6.92850819 |
| 7 | drug transport (GO:0015893) | 6.91345245 |
| 8 | organic cation transport (GO:0015695) | 6.24468496 |
| 9 | phosphate ion transport (GO:0006817) | 6.22892940 |
| 10 | cysteine metabolic process (GO:0006534) | 6.16707226 |
| 11 | drug catabolic process (GO:0042737) | 6.05135949 |
| 12 | exogenous drug catabolic process (GO:0042738) | 5.93159442 |
| 13 | L-phenylalanine catabolic process (GO:0006559) | 5.93143821 |
| 14 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.93143821 |
| 15 | L-phenylalanine metabolic process (GO:0006558) | 5.85087646 |
| 16 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.85087646 |
| 17 | axonemal dynein complex assembly (GO:0070286) | 5.80299260 |
| 18 | response to mercury ion (GO:0046689) | 5.47519188 |
| 19 | aromatic amino acid family catabolic process (GO:0009074) | 5.38851039 |
| 20 | quaternary ammonium group transport (GO:0015697) | 5.34774654 |
| 21 | phosphate ion transmembrane transport (GO:0035435) | 5.23398106 |
| 22 | cellular modified amino acid catabolic process (GO:0042219) | 5.07204063 |
| 23 | aspartate family amino acid catabolic process (GO:0009068) | 5.06249442 |
| 24 | short-chain fatty acid metabolic process (GO:0046459) | 5.05760069 |
| 25 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.01963537 |
| 26 | homocysteine metabolic process (GO:0050667) | 4.99874244 |
| 27 | serine family amino acid catabolic process (GO:0009071) | 4.99845409 |
| 28 | indole-containing compound catabolic process (GO:0042436) | 4.92170674 |
| 29 | indolalkylamine catabolic process (GO:0046218) | 4.92170674 |
| 30 | tryptophan catabolic process (GO:0006569) | 4.92170674 |
| 31 | tricarboxylic acid metabolic process (GO:0072350) | 4.89968591 |
| 32 | tryptophan metabolic process (GO:0006568) | 4.70100346 |
| 33 | amino-acid betaine metabolic process (GO:0006577) | 4.58642054 |
| 34 | vitamin D metabolic process (GO:0042359) | 4.58290057 |
| 35 | serine family amino acid metabolic process (GO:0009069) | 4.51715276 |
| 36 | cilium or flagellum-dependent cell motility (GO:0001539) | 4.48521432 |
| 37 | branched-chain amino acid metabolic process (GO:0009081) | 4.47557518 |
| 38 | cilium movement (GO:0003341) | 4.43797482 |
| 39 | nonribosomal peptide biosynthetic process (GO:0019184) | 4.42986407 |
| 40 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 4.42920604 |
| 41 | cellular ketone body metabolic process (GO:0046950) | 4.41159403 |
| 42 | sulfur amino acid catabolic process (GO:0000098) | 4.40550555 |
| 43 | excretion (GO:0007588) | 4.36949795 |
| 44 | negative regulation of sterol transport (GO:0032372) | 4.30779990 |
| 45 | negative regulation of cholesterol transport (GO:0032375) | 4.30779990 |
| 46 | glutamate metabolic process (GO:0006536) | 4.20830438 |
| 47 | renal absorption (GO:0070293) | 4.17215882 |
| 48 | epithelial cilium movement (GO:0003351) | 4.15508138 |
| 49 | valine metabolic process (GO:0006573) | 4.13150982 |
| 50 | serine family amino acid biosynthetic process (GO:0009070) | 4.11586745 |
| 51 | fructose metabolic process (GO:0006000) | 4.11219670 |
| 52 | cellular amino acid catabolic process (GO:0009063) | 4.10670816 |
| 53 | alpha-amino acid catabolic process (GO:1901606) | 4.09918523 |
| 54 | fatty acid beta-oxidation (GO:0006635) | 4.08406194 |
| 55 | kynurenine metabolic process (GO:0070189) | 4.05719772 |
| 56 | phosphate ion homeostasis (GO:0055062) | 4.04971437 |
| 57 | trivalent inorganic anion homeostasis (GO:0072506) | 4.04971437 |
| 58 | proline metabolic process (GO:0006560) | 4.04570658 |
| 59 | glutathione biosynthetic process (GO:0006750) | 4.02324089 |
| 60 | axon ensheathment in central nervous system (GO:0032291) | 4.00810529 |
| 61 | central nervous system myelination (GO:0022010) | 4.00810529 |
| 62 | modified amino acid transport (GO:0072337) | 3.98243703 |
| 63 | 2-oxoglutarate metabolic process (GO:0006103) | 3.95809956 |
| 64 | aromatic amino acid family metabolic process (GO:0009072) | 3.95397451 |
| 65 | negative regulation of fibrinolysis (GO:0051918) | 3.94639665 |
| 66 | branched-chain amino acid catabolic process (GO:0009083) | 3.93434744 |
| 67 | amino-acid betaine transport (GO:0015838) | 3.91191872 |
| 68 | carnitine transport (GO:0015879) | 3.91191872 |
| 69 | fatty acid oxidation (GO:0019395) | 3.90887082 |
| 70 | lipid oxidation (GO:0034440) | 3.90613472 |
| 71 | carnitine metabolic process (GO:0009437) | 3.90582555 |
| 72 | vitamin transmembrane transport (GO:0035461) | 3.90037675 |
| 73 | intestinal cholesterol absorption (GO:0030299) | 3.84988239 |
| 74 | acetyl-CoA metabolic process (GO:0006084) | 3.82809161 |
| 75 | ketone body metabolic process (GO:1902224) | 3.79465647 |
| 76 | regulation of fibrinolysis (GO:0051917) | 3.77989779 |
| 77 | metanephric tubule development (GO:0072170) | 3.71852893 |
| 78 | metanephric nephron tubule development (GO:0072234) | 3.71852893 |
| 79 | toxin transport (GO:1901998) | 3.71013643 |
| 80 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 3.69109866 |
| 81 | organic acid catabolic process (GO:0016054) | 3.66792451 |
| 82 | carboxylic acid catabolic process (GO:0046395) | 3.66792451 |
| 83 | bile acid biosynthetic process (GO:0006699) | 3.65676206 |
| 84 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.65045811 |
| 85 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.63511064 |
| 86 | protein carboxylation (GO:0018214) | 3.63511064 |
| 87 | fatty acid catabolic process (GO:0009062) | 3.58898883 |
| 88 | regulation of protein activation cascade (GO:2000257) | 3.56020611 |
| 89 | monocarboxylic acid catabolic process (GO:0072329) | 3.54167033 |
| 90 | alpha-linolenic acid metabolic process (GO:0036109) | 3.53482176 |
| 91 | regulation of bile acid biosynthetic process (GO:0070857) | 3.50047929 |
| 92 | indolalkylamine metabolic process (GO:0006586) | 3.47195734 |
| 93 | flavonoid metabolic process (GO:0009812) | 3.45232754 |
| 94 | aldehyde catabolic process (GO:0046185) | 3.44485501 |
| 95 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.42646669 |
| 96 | metanephric nephron epithelium development (GO:0072243) | 3.39797807 |
| 97 | benzene-containing compound metabolic process (GO:0042537) | 3.39725519 |
| 98 | regulation of complement activation (GO:0030449) | 3.39082034 |
| 99 | polyol transport (GO:0015791) | 3.38651742 |
| 100 | drug metabolic process (GO:0017144) | 3.38194224 |
| 101 | indole-containing compound metabolic process (GO:0042430) | 3.37499319 |
| 102 | glutamine family amino acid catabolic process (GO:0009065) | 3.37473990 |
| 103 | ethanol metabolic process (GO:0006067) | 3.31131389 |
| 104 | regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095) | 3.30851257 |
| 105 | sodium-independent organic anion transport (GO:0043252) | 3.30591237 |
| 106 | glycoside metabolic process (GO:0016137) | 3.29849745 |
| 107 | glutathione metabolic process (GO:0006749) | 3.29035209 |
| 108 | amine catabolic process (GO:0009310) | 3.28750039 |
| 109 | cellular biogenic amine catabolic process (GO:0042402) | 3.28750039 |
| 110 | primary alcohol catabolic process (GO:0034310) | 3.27827718 |
| 111 | peptide biosynthetic process (GO:0043043) | 3.26975581 |
| 112 | response to phenylpropanoid (GO:0080184) | 3.25659356 |
| 113 | regulation of cholesterol homeostasis (GO:2000188) | 3.25172983 |
| 114 | uronic acid metabolic process (GO:0006063) | 3.24032719 |
| 115 | glucuronate metabolic process (GO:0019585) | 3.24032719 |
| 116 | regulation of non-canonical Wnt signaling pathway (GO:2000050) | 3.21129447 |
| 117 | tyrosine metabolic process (GO:0006570) | 3.20462686 |
| 118 | response to growth hormone (GO:0060416) | 3.20336490 |
| 119 | small molecule catabolic process (GO:0044282) | 3.19607381 |
| 120 | dicarboxylic acid metabolic process (GO:0043648) | 3.18964606 |
| 121 | negative regulation of astrocyte differentiation (GO:0048712) | 3.17672403 |
| 122 | motile cilium assembly (GO:0044458) | 3.16343637 |
| 123 | glutathione derivative biosynthetic process (GO:1901687) | 3.16258785 |
| 124 | glutathione derivative metabolic process (GO:1901685) | 3.16258785 |
| 125 | regulation of gene silencing by RNA (GO:0060966) | 3.15978035 |
| 126 | regulation of posttranscriptional gene silencing (GO:0060147) | 3.15978035 |
| 127 | regulation of gene silencing by miRNA (GO:0060964) | 3.15978035 |
| 128 | cellular glucuronidation (GO:0052695) | 3.13023623 |
| 129 | peptide catabolic process (GO:0043171) | 3.12148233 |
| 130 | biotin metabolic process (GO:0006768) | 3.11693256 |
| 131 | blood coagulation, intrinsic pathway (GO:0007597) | 3.07924499 |
| 132 | plasma lipoprotein particle assembly (GO:0034377) | 3.06741878 |
| 133 | plasma lipoprotein particle remodeling (GO:0034369) | 3.05917681 |
| 134 | protein-lipid complex remodeling (GO:0034368) | 3.05917681 |
| 135 | macromolecular complex remodeling (GO:0034367) | 3.05917681 |
| 136 | regulation of apoptotic cell clearance (GO:2000425) | 3.05665728 |
| 137 | nephron epithelium morphogenesis (GO:0072088) | 3.05102881 |
| 138 | nephron tubule morphogenesis (GO:0072078) | 3.05102881 |
| 139 | low-density lipoprotein particle remodeling (GO:0034374) | 3.02182047 |
| 140 | cholesterol efflux (GO:0033344) | 3.00556924 |
| 141 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.94439166 |
| 142 | ethanol oxidation (GO:0006069) | 2.91794087 |
| 143 | glycine metabolic process (GO:0006544) | 2.90355556 |
| 144 | axoneme assembly (GO:0035082) | 2.88161788 |
| 145 | C4-dicarboxylate transport (GO:0015740) | 2.85738523 |
| 146 | lung epithelium development (GO:0060428) | 2.85295555 |
| 147 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.84296824 |
| 148 | cellular sodium ion homeostasis (GO:0006883) | 2.83425501 |
| 149 | regulation of cilium movement (GO:0003352) | 2.83085756 |
| 150 | otic vesicle formation (GO:0030916) | 2.78134312 |
| 151 | sodium ion homeostasis (GO:0055078) | 2.74333943 |
| 152 | high-density lipoprotein particle remodeling (GO:0034375) | 2.72099881 |
| 153 | gamma-aminobutyric acid transport (GO:0015812) | 2.69716568 |
| 154 | collecting duct development (GO:0072044) | 2.63610644 |
| 155 | peptidyl-glutamic acid modification (GO:0018200) | 2.62991323 |
| 156 | reverse cholesterol transport (GO:0043691) | 2.62539180 |
| 157 | metanephric epithelium development (GO:0072207) | 2.60563979 |
| 158 | plasma lipoprotein particle organization (GO:0071827) | 2.59521239 |
| 159 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.59173492 |
| 160 | regulation of cholesterol esterification (GO:0010872) | 2.58672978 |
| 161 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 2.57996891 |
| 162 | protein-lipid complex assembly (GO:0065005) | 2.57316497 |
| 163 | neuronal action potential propagation (GO:0019227) | 2.57029062 |
| 164 | L-serine metabolic process (GO:0006563) | 2.55756989 |
| 165 | negative regulation of protein localization to cell surface (GO:2000009) | 2.55639736 |
| 166 | negative regulation of sodium ion transport (GO:0010766) | 2.54227508 |
| 167 | regulation of plasminogen activation (GO:0010755) | 2.47265028 |
| 168 | peristalsis (GO:0030432) | 2.46360010 |
| 169 | postsynaptic membrane organization (GO:0001941) | 2.46019523 |
| 170 | renal tubule morphogenesis (GO:0061333) | 2.43254910 |
| 171 | complement activation, alternative pathway (GO:0006957) | 2.42319403 |
| 172 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger (GO:0007199 | 2.40281697 |
| 173 | protein-lipid complex subunit organization (GO:0071825) | 2.35423797 |
| 174 | behavioral response to nicotine (GO:0035095) | 2.34326385 |
| 175 | cochlea development (GO:0090102) | 2.33843650 |
| 176 | L-ascorbic acid metabolic process (GO:0019852) | 2.32115598 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.38434011 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.18040303 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.15858275 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.65778964 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.25323469 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.36002874 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.27457798 |
| 8 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.12486665 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.68640310 |
| 10 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.64169463 |
| 11 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.55252298 |
| 12 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.27833243 |
| 13 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.18746234 |
| 14 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.14822151 |
| 15 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.13563176 |
| 16 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.09129672 |
| 17 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.06711899 |
| 18 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.05421438 |
| 19 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.04895777 |
| 20 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.04313690 |
| 21 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.02913798 |
| 22 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.92045166 |
| 23 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.91804847 |
| 24 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.87232134 |
| 25 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.79163263 |
| 26 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.73323445 |
| 27 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.72573115 |
| 28 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.72343934 |
| 29 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.69394258 |
| 30 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.57065156 |
| 31 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.54471021 |
| 32 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.52320762 |
| 33 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.51981547 |
| 34 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.45418857 |
| 35 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.44305457 |
| 36 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.43462323 |
| 37 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.42610209 |
| 38 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.41499143 |
| 39 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.40969017 |
| 40 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.40062628 |
| 41 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.38429671 |
| 42 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.37635209 |
| 43 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.34998736 |
| 44 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.32688951 |
| 45 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.27895343 |
| 46 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.27376527 |
| 47 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.27284274 |
| 48 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.27284274 |
| 49 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.23795525 |
| 50 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.22235643 |
| 51 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.22235643 |
| 52 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.22043022 |
| 53 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.21742584 |
| 54 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.21485647 |
| 55 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.20884413 |
| 56 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.20077523 |
| 57 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.18223818 |
| 58 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.15865451 |
| 59 | P300_19829295_ChIP-Seq_ESCs_Human | 1.14583095 |
| 60 | FUS_26573619_Chip-Seq_HEK293_Human | 1.13451568 |
| 61 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.13232511 |
| 62 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.13111591 |
| 63 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.12800188 |
| 64 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.12578182 |
| 65 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.12562315 |
| 66 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.12505312 |
| 67 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.12470157 |
| 68 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.12005002 |
| 69 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.11760030 |
| 70 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.10215113 |
| 71 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.09316822 |
| 72 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.09273259 |
| 73 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.08916268 |
| 74 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.08771458 |
| 75 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.08733419 |
| 76 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.08579176 |
| 77 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.07390684 |
| 78 | RXR_22108803_ChIP-Seq_LS180_Human | 1.07212066 |
| 79 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.06350213 |
| 80 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.05160026 |
| 81 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.04052930 |
| 82 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.04052930 |
| 83 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.04052930 |
| 84 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.03940985 |
| 85 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.03772145 |
| 86 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.02808276 |
| 87 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.02393382 |
| 88 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.01735343 |
| 89 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.01717653 |
| 90 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00762603 |
| 91 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.00266936 |
| 92 | * ER_23166858_ChIP-Seq_MCF-7_Human | 1.00181579 |
| 93 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.99567756 |
| 94 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.99312156 |
| 95 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.99278522 |
| 96 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.98727361 |
| 97 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.98486467 |
| 98 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.98118193 |
| 99 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.97488677 |
| 100 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.96970048 |
| 101 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.96736747 |
| 102 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.95623274 |
| 103 | * STAT3_23295773_ChIP-Seq_U87_Human | 0.95393648 |
| 104 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.95323831 |
| 105 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.95107954 |
| 106 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.94564340 |
| 107 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.93950038 |
| 108 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.93263926 |
| 109 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.93203528 |
| 110 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.92906198 |
| 111 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.92862169 |
| 112 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.92370454 |
| 113 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.92043897 |
| 114 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.91692525 |
| 115 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.91264116 |
| 116 | * AR_19668381_ChIP-Seq_PC3_Human | 0.91113106 |
| 117 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.90315601 |
| 118 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.89936939 |
| 119 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.89900640 |
| 120 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.88982580 |
| 121 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.88937057 |
| 122 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.88425267 |
| 123 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.88425267 |
| 124 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.88104060 |
| 125 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.87974507 |
| 126 | TCF4_23295773_ChIP-Seq_U87_Human | 0.87938958 |
| 127 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.87616758 |
| 128 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.87430856 |
| 129 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.87154847 |
| 130 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.86386636 |
| 131 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.83957539 |
| 132 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.83957539 |
| 133 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.82059603 |
| 134 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.81668198 |
| 135 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.79668126 |
| 136 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.76785399 |
| 137 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.75552834 |
| 138 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.75136005 |
| 139 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.74626345 |
| 140 | GATA1_19941826_ChIP-Seq_K562_Human | 0.74458602 |
| 141 | VDR_22108803_ChIP-Seq_LS180_Human | 0.74316869 |
| 142 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.74235762 |
| 143 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.72825648 |
| 144 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.72688832 |
| 145 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.72219376 |
| 146 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.71777503 |
| 147 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.71774003 |
| 148 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.69340324 |
| 149 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.68951791 |
| 150 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.68642265 |
| 151 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.67995443 |
| 152 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.67989543 |
| 153 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.67985536 |
| 154 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.67137366 |
| 155 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.67114632 |
| 156 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.66870626 |
| 157 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.66350375 |
| 158 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.65154313 |
| 159 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.64820807 |
| 160 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.64582058 |
| 161 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.64173856 |
| 162 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.64111681 |
| 163 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.63978275 |
| 164 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.63881492 |
| 165 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.63785449 |
| 166 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.62641784 |
| 167 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.62516208 |
| 168 | CBP_21632823_ChIP-Seq_H3396_Human | 0.60902175 |
| 169 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.60774381 |
| 170 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.59683366 |
| 171 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.59554389 |
| 172 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.59469508 |
| 173 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.58799517 |
| 174 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.58259107 |
| 175 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.58042497 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 7.81727364 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 6.09221904 |
| 3 | MP0004043_abnormal_pH_regulation | 4.82690334 |
| 4 | MP0005332_abnormal_amino_acid | 4.65980013 |
| 5 | MP0004019_abnormal_vitamin_homeostasis | 4.48272711 |
| 6 | MP0003195_calcinosis | 3.71491390 |
| 7 | MP0008875_abnormal_xenobiotic_pharmacok | 3.58919851 |
| 8 | MP0005365_abnormal_bile_salt | 3.51633036 |
| 9 | MP0000566_synostosis | 3.35631461 |
| 10 | MP0002138_abnormal_hepatobiliary_system | 3.34795490 |
| 11 | MP0009643_abnormal_urine_homeostasis | 3.31556461 |
| 12 | MP0005085_abnormal_gallbladder_physiolo | 3.29015134 |
| 13 | MP0006292_abnormal_olfactory_placode | 3.11909870 |
| 14 | MP0003122_maternal_imprinting | 2.94009746 |
| 15 | MP0001765_abnormal_ion_homeostasis | 2.93559177 |
| 16 | MP0003252_abnormal_bile_duct | 2.79830015 |
| 17 | MP0005636_abnormal_mineral_homeostasis | 2.67643182 |
| 18 | MP0001756_abnormal_urination | 2.49711138 |
| 19 | MP0005058_abnormal_lysosome_morphology | 2.38274654 |
| 20 | MP0002136_abnormal_kidney_physiology | 2.33699651 |
| 21 | MP0003136_yellow_coat_color | 2.29544123 |
| 22 | MP0003806_abnormal_nucleotide_metabolis | 2.08986161 |
| 23 | MP0001958_emphysema | 1.99819563 |
| 24 | MP0003191_abnormal_cellular_cholesterol | 1.97544431 |
| 25 | MP0003878_abnormal_ear_physiology | 1.94099470 |
| 26 | MP0005377_hearing/vestibular/ear_phenot | 1.94099470 |
| 27 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.91700020 |
| 28 | MP0010329_abnormal_lipoprotein_level | 1.88032552 |
| 29 | MP0003186_abnormal_redox_activity | 1.80924881 |
| 30 | MP0004270_analgesia | 1.79029007 |
| 31 | MP0009840_abnormal_foam_cell | 1.72159146 |
| 32 | MP0003880_abnormal_central_pattern | 1.66681296 |
| 33 | MP0008789_abnormal_olfactory_epithelium | 1.64317327 |
| 34 | MP0001293_anophthalmia | 1.64177288 |
| 35 | MP0004885_abnormal_endolymph | 1.63613065 |
| 36 | MP0002653_abnormal_ependyma_morphology | 1.61728157 |
| 37 | MP0001529_abnormal_vocalization | 1.58819236 |
| 38 | MP0002938_white_spotting | 1.57870210 |
| 39 | MP0010030_abnormal_orbit_morphology | 1.57036241 |
| 40 | MP0005319_abnormal_enzyme/_coenzyme | 1.56033914 |
| 41 | MP0005423_abnormal_somatic_nervous | 1.53796360 |
| 42 | MP0003941_abnormal_skin_development | 1.53709120 |
| 43 | MP0002118_abnormal_lipid_homeostasis | 1.46410567 |
| 44 | MP0005499_abnormal_olfactory_system | 1.45540637 |
| 45 | MP0005394_taste/olfaction_phenotype | 1.45540637 |
| 46 | MP0003123_paternal_imprinting | 1.45413066 |
| 47 | MP0004133_heterotaxia | 1.44501631 |
| 48 | MP0005083_abnormal_biliary_tract | 1.39265831 |
| 49 | MP0001984_abnormal_olfaction | 1.39261583 |
| 50 | MP0005451_abnormal_body_composition | 1.39178249 |
| 51 | MP0001486_abnormal_startle_reflex | 1.32549021 |
| 52 | MP0001666_abnormal_nutrient_absorption | 1.32358760 |
| 53 | MP0005551_abnormal_eye_electrophysiolog | 1.32153082 |
| 54 | MP0009780_abnormal_chondrocyte_physiolo | 1.31722232 |
| 55 | MP0003690_abnormal_glial_cell | 1.31485849 |
| 56 | MP0009046_muscle_twitch | 1.29639785 |
| 57 | MP0003300_gastrointestinal_ulcer | 1.26041536 |
| 58 | MP0003890_abnormal_embryonic-extraembry | 1.25916452 |
| 59 | MP0003121_genomic_imprinting | 1.25173038 |
| 60 | MP0002249_abnormal_larynx_morphology | 1.25071003 |
| 61 | MP0003329_amyloid_beta_deposits | 1.24707978 |
| 62 | MP0002160_abnormal_reproductive_system | 1.23809124 |
| 63 | MP0001270_distended_abdomen | 1.21697201 |
| 64 | MP0003938_abnormal_ear_development | 1.19173667 |
| 65 | MP0000609_abnormal_liver_physiology | 1.18752363 |
| 66 | MP0000678_abnormal_parathyroid_gland | 1.18250049 |
| 67 | MP0003942_abnormal_urinary_system | 1.16694427 |
| 68 | MP0002822_catalepsy | 1.14883573 |
| 69 | MP0000538_abnormal_urinary_bladder | 1.14865788 |
| 70 | MP0000604_amyloidosis | 1.14060773 |
| 71 | MP0000049_abnormal_middle_ear | 1.13228373 |
| 72 | MP0005670_abnormal_white_adipose | 1.12247612 |
| 73 | MP0001764_abnormal_homeostasis | 1.11658112 |
| 74 | MP0002734_abnormal_mechanical_nocicepti | 1.11516054 |
| 75 | MP0001968_abnormal_touch/_nociception | 1.10511233 |
| 76 | MP0002064_seizures | 1.09589445 |
| 77 | MP0004858_abnormal_nervous_system | 1.08908520 |
| 78 | MP0009745_abnormal_behavioral_response | 1.08079159 |
| 79 | MP0005084_abnormal_gallbladder_morpholo | 1.08050008 |
| 80 | MP0003172_abnormal_lysosome_physiology | 1.06838509 |
| 81 | MP0002272_abnormal_nervous_system | 1.06593806 |
| 82 | MP0005535_abnormal_body_temperature | 1.05686230 |
| 83 | MP0000230_abnormal_systemic_arterial | 1.05618769 |
| 84 | MP0008961_abnormal_basal_metabolism | 1.04866398 |
| 85 | MP0002233_abnormal_nose_morphology | 1.02709349 |
| 86 | MP0010368_abnormal_lymphatic_system | 1.02639221 |
| 87 | MP0003635_abnormal_synaptic_transmissio | 1.02573967 |
| 88 | MP0000631_abnormal_neuroendocrine_gland | 1.02531594 |
| 89 | MP0002168_other_aberrant_phenotype | 1.00434967 |
| 90 | MP0006036_abnormal_mitochondrial_physio | 0.99424324 |
| 91 | MP0003718_maternal_effect | 0.96010391 |
| 92 | MP0009764_decreased_sensitivity_to | 0.95869757 |
| 93 | MP0002282_abnormal_trachea_morphology | 0.95169687 |
| 94 | MP0003937_abnormal_limbs/digits/tail_de | 0.93063384 |
| 95 | MP0000778_abnormal_nervous_system | 0.91214640 |
| 96 | MP0005646_abnormal_pituitary_gland | 0.90172669 |
| 97 | MP0002876_abnormal_thyroid_physiology | 0.90135131 |
| 98 | MP0000026_abnormal_inner_ear | 0.90062204 |
| 99 | MP0000955_abnormal_spinal_cord | 0.89361766 |
| 100 | MP0002234_abnormal_pharynx_morphology | 0.89183414 |
| 101 | MP0002135_abnormal_kidney_morphology | 0.88099448 |
| 102 | MP0003868_abnormal_feces_composition | 0.87910383 |
| 103 | MP0002928_abnormal_bile_duct | 0.87693874 |
| 104 | MP0003075_altered_response_to | 0.87591776 |
| 105 | MP0004859_abnormal_synaptic_plasticity | 0.87397255 |
| 106 | MP0009642_abnormal_blood_homeostasis | 0.87032058 |
| 107 | MP0002557_abnormal_social/conspecific_i | 0.86849647 |
| 108 | MP0002638_abnormal_pupillary_reflex | 0.86696634 |
| 109 | MP0001963_abnormal_hearing_physiology | 0.85991425 |
| 110 | MP0001299_abnormal_eye_distance/ | 0.85225072 |
| 111 | MP0002063_abnormal_learning/memory/cond | 0.84645292 |
| 112 | MP0000534_abnormal_ureter_morphology | 0.84524174 |
| 113 | MP0002735_abnormal_chemical_nociception | 0.84485558 |
| 114 | MP0002572_abnormal_emotion/affect_behav | 0.84292974 |
| 115 | MP0005666_abnormal_adipose_tissue | 0.84187386 |
| 116 | MP0003638_abnormal_response/metabolism_ | 0.80842835 |
| 117 | MP0002736_abnormal_nociception_after | 0.80812341 |
| 118 | MP0002089_abnormal_postnatal_growth/wei | 0.79506459 |
| 119 | MP0003567_abnormal_fetal_cardiomyocyte | 0.79250221 |
| 120 | MP0003950_abnormal_plasma_membrane | 0.78518877 |
| 121 | MP0002184_abnormal_innervation | 0.76941406 |
| 122 | MP0004147_increased_porphyrin_level | 0.76794955 |
| 123 | MP0002752_abnormal_somatic_nervous | 0.74557127 |
| 124 | MP0002067_abnormal_sensory_capabilities | 0.73977266 |
| 125 | MP0001286_abnormal_eye_development | 0.73946544 |
| 126 | MP0008469_abnormal_protein_level | 0.73880655 |
| 127 | MP0006276_abnormal_autonomic_nervous | 0.72145785 |
| 128 | MP0000920_abnormal_myelination | 0.72055979 |
| 129 | MP0003315_abnormal_perineum_morphology | 0.71745872 |
| 130 | MP0005187_abnormal_penis_morphology | 0.71343605 |
| 131 | MP0000598_abnormal_liver_morphology | 0.69906954 |
| 132 | MP0003011_delayed_dark_adaptation | 0.68491127 |
| 133 | MP0005167_abnormal_blood-brain_barrier | 0.68098125 |
| 134 | MP0001661_extended_life_span | 0.66693926 |
| 135 | MP0002896_abnormal_bone_mineralization | 0.66037864 |
| 136 | MP0005165_increased_susceptibility_to | 0.65578337 |
| 137 | MP0003705_abnormal_hypodermis_morpholog | 0.64495486 |
| 138 | MP0002254_reproductive_system_inflammat | 0.63357794 |
| 139 | MP0005395_other_phenotype | 0.58578651 |
| 140 | MP0003633_abnormal_nervous_system | 0.58414863 |
| 141 | MP0005166_decreased_susceptibility_to | 0.56900663 |
| 142 | MP0002078_abnormal_glucose_homeostasis | 0.56730445 |
| 143 | MP0000747_muscle_weakness | 0.54212265 |
| 144 | MP0003646_muscle_fatigue | 0.51646884 |
| 145 | MP0002796_impaired_skin_barrier | 0.50436286 |
| 146 | MP0002971_abnormal_brown_adipose | 0.48867759 |
| 147 | MP0003656_abnormal_erythrocyte_physiolo | 0.47306426 |
| 148 | MP0004264_abnormal_extraembryonic_tissu | 0.44997922 |
| 149 | MP0005220_abnormal_exocrine_pancreas | 0.44857506 |
| 150 | MP0003953_abnormal_hormone_level | 0.44646620 |
| 151 | MP0001485_abnormal_pinna_reflex | 0.43703735 |
| 152 | MP0002069_abnormal_eating/drinking_beha | 0.43524317 |
| 153 | MP0003631_nervous_system_phenotype | 0.43330235 |
| 154 | MP0005595_abnormal_vascular_smooth | 0.42897706 |
| 155 | MP0004742_abnormal_vestibular_system | 0.42143944 |
| 156 | MP0005376_homeostasis/metabolism_phenot | 0.40701716 |
| 157 | MP0002998_abnormal_bone_remodeling | 0.39139186 |
| 158 | MP0005408_hypopigmentation | 0.38844241 |
| 159 | MP0009763_increased_sensitivity_to | 0.37891637 |
| 160 | MP0005647_abnormal_sex_gland | 0.36739657 |
| 161 | MP0003879_abnormal_hair_cell | 0.36737876 |
| 162 | MP0006035_abnormal_mitochondrial_morpho | 0.34020384 |
| 163 | MP0002115_abnormal_skeleton_extremities | 0.33945168 |
| 164 | MP0009765_abnormal_xenobiotic_induced | 0.33350280 |
| 165 | MP0000371_diluted_coat_color | 0.33012794 |
| 166 | MP0002295_abnormal_pulmonary_circulatio | 0.32891448 |
| 167 | MP0009384_cardiac_valve_regurgitation | 0.32571263 |
| 168 | MP0008874_decreased_physiological_sensi | 0.32522541 |
| 169 | MP0009672_abnormal_birth_weight | 0.30547926 |
| 170 | MP0003724_increased_susceptibility_to | 0.30516209 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased circulating renin level (HP:0000848) | 6.81051317 |
| 2 | Hypokalemic alkalosis (HP:0001949) | 6.40290747 |
| 3 | Gout (HP:0001997) | 6.39152169 |
| 4 | Metabolic alkalosis (HP:0200114) | 6.32634603 |
| 5 | Polyuria (HP:0000103) | 5.67717266 |
| 6 | Hypomagnesemia (HP:0002917) | 5.61692262 |
| 7 | Hyperactive renin-angiotensin system (HP:0000841) | 5.58747399 |
| 8 | Abnormal urine output (HP:0012590) | 5.45236049 |
| 9 | Abnormality of renal excretion (HP:0011036) | 5.16651368 |
| 10 | Abnormality of chloride homeostasis (HP:0011422) | 5.12363200 |
| 11 | Proximal tubulopathy (HP:0000114) | 5.00247654 |
| 12 | Hyperglycinuria (HP:0003108) | 4.98658119 |
| 13 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.90598960 |
| 14 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 4.84653609 |
| 15 | Abnormality of magnesium homeostasis (HP:0004921) | 4.72296914 |
| 16 | Abnormal respiratory motile cilium morphology (HP:0005938) | 4.66493475 |
| 17 | Abnormal respiratory epithelium morphology (HP:0012253) | 4.66493475 |
| 18 | Abnormal drinking behavior (HP:0030082) | 4.59224751 |
| 19 | Polydipsia (HP:0001959) | 4.59224751 |
| 20 | Alkalosis (HP:0001948) | 4.56931941 |
| 21 | Hyperuricemia (HP:0002149) | 4.44241902 |
| 22 | Increased purine levels (HP:0004368) | 4.44241902 |
| 23 | Abnormal respiratory motile cilium physiology (HP:0012261) | 4.37571475 |
| 24 | Abnormal ciliary motility (HP:0012262) | 4.34821383 |
| 25 | Absent/shortened dynein arms (HP:0200106) | 4.33216213 |
| 26 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 4.33216213 |
| 27 | Abnormality of glycine metabolism (HP:0010895) | 4.31356734 |
| 28 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.31356734 |
| 29 | Abnormality of purine metabolism (HP:0004352) | 4.30084694 |
| 30 | Abnormality of renin-angiotensin system (HP:0000847) | 4.10120096 |
| 31 | Generalized aminoaciduria (HP:0002909) | 4.06142825 |
| 32 | Renal salt wasting (HP:0000127) | 3.97171588 |
| 33 | Hyperaldosteronism (HP:0000859) | 3.94230146 |
| 34 | Ketosis (HP:0001946) | 3.82550245 |
| 35 | Rhinitis (HP:0012384) | 3.81880371 |
| 36 | Ketoacidosis (HP:0001993) | 3.79218084 |
| 37 | Tetany (HP:0001281) | 3.71298391 |
| 38 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.54808916 |
| 39 | Prolonged partial thromboplastin time (HP:0003645) | 3.50422963 |
| 40 | Abnormality of urine glucose concentration (HP:0011016) | 3.41548375 |
| 41 | Glycosuria (HP:0003076) | 3.41548375 |
| 42 | Abnormality of nucleobase metabolism (HP:0010932) | 3.39909769 |
| 43 | Renal tubular acidosis (HP:0001947) | 3.35254528 |
| 44 | Hypercalciuria (HP:0002150) | 3.34516696 |
| 45 | Hyperglycinemia (HP:0002154) | 3.29675503 |
| 46 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.24248591 |
| 47 | Chronic bronchitis (HP:0004469) | 3.23983338 |
| 48 | Hyperammonemia (HP:0001987) | 3.21680453 |
| 49 | Hydroxyprolinuria (HP:0003080) | 3.21628973 |
| 50 | Abnormality of proline metabolism (HP:0010907) | 3.21628973 |
| 51 | Xanthomatosis (HP:0000991) | 3.15289329 |
| 52 | Hypokalemia (HP:0002900) | 3.08249658 |
| 53 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.06917922 |
| 54 | Delayed CNS myelination (HP:0002188) | 2.95523320 |
| 55 | Hyperphosphaturia (HP:0003109) | 2.92916327 |
| 56 | Vascular calcification (HP:0004934) | 2.92399224 |
| 57 | Abnormal urine phosphate concentration (HP:0012599) | 2.79731732 |
| 58 | Rickets (HP:0002748) | 2.77099781 |
| 59 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.76962096 |
| 60 | Nephrolithiasis (HP:0000787) | 2.75260116 |
| 61 | Hypophosphatemia (HP:0002148) | 2.69935411 |
| 62 | Vacuolated lymphocytes (HP:0001922) | 2.69322506 |
| 63 | Nephrocalcinosis (HP:0000121) | 2.65216208 |
| 64 | Intrahepatic cholestasis (HP:0001406) | 2.61825445 |
| 65 | True hermaphroditism (HP:0010459) | 2.60964170 |
| 66 | Delayed epiphyseal ossification (HP:0002663) | 2.60336290 |
| 67 | Abnormality of potassium homeostasis (HP:0011042) | 2.60238972 |
| 68 | Cardiovascular calcification (HP:0011915) | 2.58985834 |
| 69 | Enlarged kidneys (HP:0000105) | 2.57743479 |
| 70 | Hypobetalipoproteinemia (HP:0003563) | 2.57271506 |
| 71 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.57020513 |
| 72 | Dicarboxylic aciduria (HP:0003215) | 2.57020513 |
| 73 | Widely patent fontanelles and sutures (HP:0004492) | 2.51473465 |
| 74 | Metabolic acidosis (HP:0001942) | 2.51021285 |
| 75 | Confusion (HP:0001289) | 2.50799653 |
| 76 | Vomiting (HP:0002013) | 2.42682347 |
| 77 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.40381538 |
| 78 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.34669937 |
| 79 | Hepatoblastoma (HP:0002884) | 2.29822349 |
| 80 | Pancreatic fibrosis (HP:0100732) | 2.28648820 |
| 81 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.28560107 |
| 82 | Bronchiectasis (HP:0002110) | 2.27093961 |
| 83 | Pancreatic cysts (HP:0001737) | 2.26797513 |
| 84 | Malnutrition (HP:0004395) | 2.26552375 |
| 85 | Complement deficiency (HP:0004431) | 2.26173986 |
| 86 | Sensorimotor neuropathy (HP:0007141) | 2.25830517 |
| 87 | Lethargy (HP:0001254) | 2.25732952 |
| 88 | Supernumerary spleens (HP:0009799) | 2.23213135 |
| 89 | Tubular atrophy (HP:0000092) | 2.16917700 |
| 90 | Metaphyseal cupping (HP:0003021) | 2.16743053 |
| 91 | Irritability (HP:0000737) | 2.15534282 |
| 92 | Dehydration (HP:0001944) | 2.12404284 |
| 93 | Hypoglycemic coma (HP:0001325) | 2.09086990 |
| 94 | Axonal loss (HP:0003447) | 2.08950922 |
| 95 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.07001834 |
| 96 | Abnormality of renal resorption (HP:0011038) | 2.06821543 |
| 97 | Methylmalonic aciduria (HP:0012120) | 2.05997938 |
| 98 | Deep venous thrombosis (HP:0002625) | 2.04758873 |
| 99 | Cystic liver disease (HP:0006706) | 2.03994755 |
| 100 | Renal tubular dysfunction (HP:0000124) | 2.03612859 |
| 101 | Abnormality of the renal medulla (HP:0100957) | 2.03335507 |
| 102 | Abnormality of sodium homeostasis (HP:0010931) | 2.02347658 |
| 103 | Abnormality of serum amino acid levels (HP:0003112) | 2.01357045 |
| 104 | Epidermoid cyst (HP:0200040) | 1.99130494 |
| 105 | Abnormal tarsal ossification (HP:0008369) | 1.96440972 |
| 106 | Elevated alkaline phosphatase (HP:0003155) | 1.93546235 |
| 107 | Hyponatremia (HP:0002902) | 1.93457756 |
| 108 | Hypophosphatemic rickets (HP:0004912) | 1.92152651 |
| 109 | Facial shape deformation (HP:0011334) | 1.91699773 |
| 110 | Potter facies (HP:0002009) | 1.91699773 |
| 111 | Neonatal onset (HP:0003623) | 1.89675242 |
| 112 | Osteomalacia (HP:0002749) | 1.87348004 |
| 113 | Late onset (HP:0003584) | 1.87165495 |
| 114 | Joint hemorrhage (HP:0005261) | 1.86073140 |
| 115 | Nausea (HP:0002018) | 1.84533618 |
| 116 | Hepatocellular carcinoma (HP:0001402) | 1.84362736 |
| 117 | Dysostosis multiplex (HP:0000943) | 1.83080320 |
| 118 | Adrenal overactivity (HP:0002717) | 1.82892836 |
| 119 | Lymphangioma (HP:0100764) | 1.82097886 |
| 120 | Nephronophthisis (HP:0000090) | 1.80400994 |
| 121 | Protuberant abdomen (HP:0001538) | 1.80369151 |
| 122 | Vaginal atresia (HP:0000148) | 1.80280575 |
| 123 | Chronic hepatic failure (HP:0100626) | 1.79386916 |
| 124 | Thin bony cortex (HP:0002753) | 1.79189944 |
| 125 | Epiphyseal dysplasia (HP:0002656) | 1.79169551 |
| 126 | Chondrocalcinosis (HP:0000934) | 1.78091191 |
| 127 | Occipital encephalocele (HP:0002085) | 1.76877355 |
| 128 | Bifid scrotum (HP:0000048) | 1.76776744 |
| 129 | Choanal stenosis (HP:0000452) | 1.76628875 |
| 130 | Genital tract atresia (HP:0001827) | 1.75812395 |
| 131 | Glomerulosclerosis (HP:0000096) | 1.75318003 |
| 132 | Nephrogenic diabetes insipidus (HP:0009806) | 1.75304187 |
| 133 | Cutaneous finger syndactyly (HP:0010554) | 1.74316011 |
| 134 | Tubulointerstitial fibrosis (HP:0005576) | 1.74151905 |
| 135 | Abnormality of the costochondral junction (HP:0000919) | 1.73849094 |
| 136 | Anophthalmia (HP:0000528) | 1.69607475 |
| 137 | Postaxial foot polydactyly (HP:0001830) | 1.68973246 |
| 138 | Myokymia (HP:0002411) | 1.67786752 |
| 139 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.67135531 |
| 140 | Coronal craniosynostosis (HP:0004440) | 1.66408415 |
| 141 | Septo-optic dysplasia (HP:0100842) | 1.65148505 |
| 142 | Hypercholesterolemia (HP:0003124) | 1.64227183 |
| 143 | Hypotension (HP:0002615) | 1.62541760 |
| 144 | Bronchomalacia (HP:0002780) | 1.60915328 |
| 145 | Abnormality of carpal bone ossification (HP:0006257) | 1.56019222 |
| 146 | Infertility (HP:0000789) | 1.53042524 |
| 147 | Focal motor seizures (HP:0011153) | 1.49839666 |
| 148 | Abnormality of the labia minora (HP:0012880) | 1.49387878 |
| 149 | Anosmia (HP:0000458) | 1.46425068 |
| 150 | Cutaneous syndactyly (HP:0012725) | 1.46282330 |
| 151 | Decreased central vision (HP:0007663) | 1.46129534 |
| 152 | Abnormal biliary tract physiology (HP:0012439) | 1.44739659 |
| 153 | Bile duct proliferation (HP:0001408) | 1.44739659 |
| 154 | Arthropathy (HP:0003040) | 1.44663094 |
| 155 | Broad alveolar ridges (HP:0000187) | 1.44125462 |
| 156 | Abnormality of midbrain morphology (HP:0002418) | 1.43985616 |
| 157 | Molar tooth sign on MRI (HP:0002419) | 1.43985616 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | WNK4 | 8.45771541 |
| 2 | OXSR1 | 6.71677671 |
| 3 | WNK3 | 6.32601560 |
| 4 | STK39 | 4.52455582 |
| 5 | BCKDK | 4.05521834 |
| 6 | SGK494 | 2.21868050 |
| 7 | SGK223 | 2.21868050 |
| 8 | NTRK3 | 1.95675745 |
| 9 | STK38L | 1.95083599 |
| 10 | MAP4K2 | 1.86123446 |
| 11 | WNK1 | 1.84725839 |
| 12 | PNCK | 1.81283830 |
| 13 | MAP3K9 | 1.76271743 |
| 14 | CASK | 1.67781588 |
| 15 | ERN1 | 1.65151516 |
| 16 | FGFR4 | 1.64680853 |
| 17 | EPHB1 | 1.60720978 |
| 18 | PDK3 | 1.56560174 |
| 19 | PDK4 | 1.56560174 |
| 20 | MARK1 | 1.52591562 |
| 21 | TYRO3 | 1.51983190 |
| 22 | TLK1 | 1.42585214 |
| 23 | ZAK | 1.38418312 |
| 24 | AKT3 | 1.38242951 |
| 25 | NEK1 | 1.31109294 |
| 26 | STK38 | 1.29471438 |
| 27 | MAP3K4 | 1.26274907 |
| 28 | SGK2 | 1.25040453 |
| 29 | FGFR1 | 1.23573012 |
| 30 | SGK3 | 1.23415048 |
| 31 | MAPKAPK5 | 1.19931479 |
| 32 | PRKD3 | 1.19444499 |
| 33 | MST1R | 1.17944347 |
| 34 | TRIB3 | 1.17917779 |
| 35 | PINK1 | 1.14114892 |
| 36 | DYRK2 | 1.14038719 |
| 37 | BMPR1B | 1.12180794 |
| 38 | GRK6 | 1.09247450 |
| 39 | PDK2 | 1.06720940 |
| 40 | GRK1 | 1.04555637 |
| 41 | LMTK2 | 1.04458681 |
| 42 | EPHA4 | 1.01838778 |
| 43 | SIK1 | 0.97820626 |
| 44 | TTK | 0.95946113 |
| 45 | TSSK6 | 0.89237044 |
| 46 | CDC7 | 0.87656433 |
| 47 | WEE1 | 0.87408540 |
| 48 | NME1 | 0.85195619 |
| 49 | BRSK1 | 0.85160629 |
| 50 | BRSK2 | 0.84850403 |
| 51 | LRRK2 | 0.84639441 |
| 52 | INSRR | 0.84407196 |
| 53 | VRK1 | 0.82842065 |
| 54 | GSK3A | 0.79279651 |
| 55 | MAP3K7 | 0.79053388 |
| 56 | PIK3CA | 0.78552986 |
| 57 | TAF1 | 0.78245980 |
| 58 | DYRK3 | 0.75426858 |
| 59 | MAPK11 | 0.74796036 |
| 60 | PTK6 | 0.71935499 |
| 61 | ADRBK2 | 0.71317414 |
| 62 | SGK1 | 0.66661793 |
| 63 | MAPK13 | 0.65861900 |
| 64 | PHKG1 | 0.65332467 |
| 65 | PHKG2 | 0.65332467 |
| 66 | PDPK1 | 0.64516367 |
| 67 | CSNK1E | 0.64230390 |
| 68 | MKNK2 | 0.64152055 |
| 69 | FGFR3 | 0.61514612 |
| 70 | MAP2K4 | 0.60604842 |
| 71 | TGFBR2 | 0.58883944 |
| 72 | ABL2 | 0.58493215 |
| 73 | PLK1 | 0.58052981 |
| 74 | PRKAA2 | 0.57797092 |
| 75 | BCR | 0.57483529 |
| 76 | EIF2AK1 | 0.56971287 |
| 77 | UHMK1 | 0.56207733 |
| 78 | ERBB4 | 0.55920546 |
| 79 | MARK2 | 0.54049059 |
| 80 | NEK6 | 0.53573504 |
| 81 | PRKCZ | 0.52388730 |
| 82 | PTK2 | 0.52306217 |
| 83 | MAPK12 | 0.51384658 |
| 84 | TNIK | 0.51121554 |
| 85 | MST4 | 0.49766817 |
| 86 | CSNK1A1 | 0.49707438 |
| 87 | PRKAA1 | 0.49085322 |
| 88 | SIK2 | 0.48667216 |
| 89 | PRKCH | 0.48458658 |
| 90 | RIPK1 | 0.46775714 |
| 91 | PLK3 | 0.46555629 |
| 92 | DYRK1A | 0.46443246 |
| 93 | TIE1 | 0.46039766 |
| 94 | CDK8 | 0.45843913 |
| 95 | MAP2K7 | 0.42981683 |
| 96 | NTRK1 | 0.42752407 |
| 97 | DAPK2 | 0.42226836 |
| 98 | PRKD2 | 0.41990748 |
| 99 | DYRK1B | 0.41963153 |
| 100 | MET | 0.41888270 |
| 101 | PDK1 | 0.41636026 |
| 102 | RPS6KA3 | 0.41226960 |
| 103 | CAMK4 | 0.40354460 |
| 104 | JAK2 | 0.40343825 |
| 105 | PLK2 | 0.40037905 |
| 106 | CAMK1D | 0.39934540 |
| 107 | CSNK1D | 0.39782513 |
| 108 | PRKACG | 0.39683850 |
| 109 | PAK3 | 0.38939834 |
| 110 | PRKCE | 0.38284530 |
| 111 | CAMKK1 | 0.37782235 |
| 112 | CAMK2B | 0.36917554 |
| 113 | CAMKK2 | 0.35246650 |
| 114 | CDK7 | 0.34817366 |
| 115 | CDK5 | 0.34750713 |
| 116 | LATS2 | 0.34654220 |
| 117 | SRPK1 | 0.34136244 |
| 118 | CAMK2A | 0.33607942 |
| 119 | CAMK1 | 0.32832940 |
| 120 | TYK2 | 0.32633899 |
| 121 | PRKCG | 0.32441341 |
| 122 | PTK2B | 0.31727885 |
| 123 | MUSK | 0.31665219 |
| 124 | IRAK2 | 0.31253053 |
| 125 | BUB1 | 0.29981298 |
| 126 | PRKG1 | 0.29066531 |
| 127 | BMX | 0.29022364 |
| 128 | PAK4 | 0.28925781 |
| 129 | AURKA | 0.28856051 |
| 130 | EPHB2 | 0.28852116 |
| 131 | PRKDC | 0.28734512 |
| 132 | MAP3K3 | 0.28217999 |
| 133 | PRKCD | 0.26347920 |
| 134 | NTRK2 | 0.24795914 |
| 135 | STK11 | 0.24624976 |
| 136 | MINK1 | 0.23535012 |
| 137 | PRKCA | 0.23415540 |
| 138 | CAMK1G | 0.22444882 |
| 139 | ERBB2 | 0.22193458 |
| 140 | PRKCQ | 0.21828997 |
| 141 | CSK | 0.21606893 |
| 142 | FGR | 0.20978680 |
| 143 | MAP3K2 | 0.20536922 |
| 144 | MAPK4 | 0.20120222 |
| 145 | PBK | 0.20062319 |
| 146 | PRKACA | 0.18471090 |
| 147 | IRAK1 | 0.18224981 |
| 148 | JAK1 | 0.17896950 |
| 149 | FGFR2 | 0.17084408 |
| 150 | KSR2 | 0.16841993 |
| 151 | PKN1 | 0.15983647 |
| 152 | PIK3CG | 0.15583213 |
| 153 | FER | 0.15559377 |
| 154 | CAMK2G | 0.15375659 |
| 155 | IGF1R | 0.14428726 |
| 156 | SRC | 0.13633904 |
| 157 | PKN2 | 0.13422430 |
| 158 | IRAK3 | 0.12036546 |
| 159 | LATS1 | 0.11941674 |
| 160 | MAP3K6 | 0.09537891 |
| 161 | ROCK1 | 0.09148272 |
| 162 | INSR | 0.08888430 |
| 163 | MAPK15 | 0.08806838 |
| 164 | KDR | 0.08595297 |
| 165 | MAP2K3 | 0.08562183 |
| 166 | MAP3K14 | 0.08435619 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Butanoate metabolism_Homo sapiens_hsa00650 | 3.30201439 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.28307694 |
| 3 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.18250675 |
| 4 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 3.08602750 |
| 5 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 3.07994235 |
| 6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.00264519 |
| 7 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.77262060 |
| 8 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.75022048 |
| 9 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.70120346 |
| 10 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.60342550 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.58677385 |
| 12 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.41627715 |
| 13 | Peroxisome_Homo sapiens_hsa04146 | 2.39425647 |
| 14 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.34967697 |
| 15 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.33198126 |
| 16 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.31599979 |
| 17 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.20377540 |
| 18 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.14841009 |
| 19 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.07759730 |
| 20 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.05066305 |
| 21 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.87585824 |
| 22 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.85867728 |
| 23 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.83951596 |
| 24 | Bile secretion_Homo sapiens_hsa04976 | 1.73542325 |
| 25 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.72806593 |
| 26 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.69955407 |
| 27 | Nicotine addiction_Homo sapiens_hsa05033 | 1.68422348 |
| 28 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.61935909 |
| 29 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.60978463 |
| 30 | Carbon metabolism_Homo sapiens_hsa01200 | 1.47587798 |
| 31 | Histidine metabolism_Homo sapiens_hsa00340 | 1.44240919 |
| 32 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.41087101 |
| 33 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.39319021 |
| 34 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.34834087 |
| 35 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.28858704 |
| 36 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.24387807 |
| 37 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.21522629 |
| 38 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.19577953 |
| 39 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.19379113 |
| 40 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.10529970 |
| 41 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.05983060 |
| 42 | Lysine degradation_Homo sapiens_hsa00310 | 1.05650512 |
| 43 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.05543252 |
| 44 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.05182118 |
| 45 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.03360981 |
| 46 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.02389686 |
| 47 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.02018561 |
| 48 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.01556031 |
| 49 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.01371081 |
| 50 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.98509233 |
| 51 | Mineral absorption_Homo sapiens_hsa04978 | 0.96298787 |
| 52 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.93923538 |
| 53 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.93661951 |
| 54 | Other glycan degradation_Homo sapiens_hsa00511 | 0.93269914 |
| 55 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.88298139 |
| 56 | GABAergic synapse_Homo sapiens_hsa04727 | 0.82743296 |
| 57 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.81652152 |
| 58 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.78807392 |
| 59 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.76773997 |
| 60 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.72343703 |
| 61 | Retinol metabolism_Homo sapiens_hsa00830 | 0.71850383 |
| 62 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.71321758 |
| 63 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.69653681 |
| 64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.68636634 |
| 65 | Cocaine addiction_Homo sapiens_hsa05030 | 0.68509122 |
| 66 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.66055516 |
| 67 | Lysosome_Homo sapiens_hsa04142 | 0.65314536 |
| 68 | Taste transduction_Homo sapiens_hsa04742 | 0.63176346 |
| 69 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.62745572 |
| 70 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.62065484 |
| 71 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.59761790 |
| 72 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.59427891 |
| 73 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.59033263 |
| 74 | Huntingtons disease_Homo sapiens_hsa05016 | 0.58874815 |
| 75 | ABC transporters_Homo sapiens_hsa02010 | 0.58785639 |
| 76 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.57098036 |
| 77 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.54897060 |
| 78 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.53056148 |
| 79 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.52949146 |
| 80 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.52525564 |
| 81 | Morphine addiction_Homo sapiens_hsa05032 | 0.51823582 |
| 82 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.49623476 |
| 83 | Insulin secretion_Homo sapiens_hsa04911 | 0.49301811 |
| 84 | Metabolic pathways_Homo sapiens_hsa01100 | 0.49202117 |
| 85 | Sulfur relay system_Homo sapiens_hsa04122 | 0.48872389 |
| 86 | Phototransduction_Homo sapiens_hsa04744 | 0.47617977 |
| 87 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.47616807 |
| 88 | Alcoholism_Homo sapiens_hsa05034 | 0.47306533 |
| 89 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.46022594 |
| 90 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.43376984 |
| 91 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.42255997 |
| 92 | Circadian rhythm_Homo sapiens_hsa04710 | 0.42240998 |
| 93 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.39990646 |
| 94 | Axon guidance_Homo sapiens_hsa04360 | 0.39960084 |
| 95 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.39123783 |
| 96 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.38178483 |
| 97 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.37316981 |
| 98 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.37115732 |
| 99 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.37061658 |
| 100 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.36497921 |
| 101 | RNA polymerase_Homo sapiens_hsa03020 | 0.34609873 |
| 102 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.33882017 |
| 103 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.32826047 |
| 104 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.32691634 |
| 105 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.27641481 |
| 106 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.24844335 |
| 107 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.24718957 |
| 108 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.24071985 |
| 109 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.22844102 |
| 110 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.21396419 |
| 111 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.17415579 |
| 112 | Insulin resistance_Homo sapiens_hsa04931 | 0.15771615 |
| 113 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.15487366 |
| 114 | Galactose metabolism_Homo sapiens_hsa00052 | 0.14849852 |
| 115 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.13759065 |
| 116 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.12989877 |
| 117 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.11315059 |
| 118 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.07695185 |
| 119 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.06670360 |
| 120 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.06299173 |
| 121 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.05633984 |
| 122 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.01600733 |
| 123 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.01142228 |
| 124 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.00100825 |
| 125 | Parkinsons disease_Homo sapiens_hsa05012 | -0.0372567 |
| 126 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0253101 |
| 127 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | -0.0232876 |
| 128 | One carbon pool by folate_Homo sapiens_hsa00670 | -0.0199425 |
| 129 | Vibrio cholerae infection_Homo sapiens_hsa05110 | -0.0076555 |

